Compounds > argipressin (4-9), (3-1')-disulfide cys(6)-
Page last updated: 2024-12-11

argipressin (4-9), (3-1')-disulfide cys(6)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

argipressin (4-9), (3-1')-disulfide Cys(6)-: AVP major metabolite identified as potent neuropeptide; RN given for all (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5490952
MeSH IDM0148877

Synonyms (12)

Synonym
vasopressin metabolite neuropeptide
glycinamide, 5-oxo-l-prolyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-arginyl-, (3-1')-disulfide with l-cysteine
pglu-asn-cys(cys)-pro-arg-gly-nh2
argipressin (4-9), (3-1')-disulfide cys(6)-
84953-77-5
5-oxo-l-prolyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-arginylglycinamide (3-1')-disulfide with l-cysteine
arginine vasopressin (4-9), (3-1')-disulfide cys(6)-
(3-1')-disulfide 6-cys-argipressin (4-9)
argipressin (4-9), (3-1')-disulfide cysteine(6)-
(pglu(4),cyt(6))avp(4-9)
DTXSID40233996
(2s)-n-[(2s)-1-[(2s)-2-[[(2s)-1-[(2-amino-2-oxoethanethioyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]-2-[[(2s)-5-oxopyrrolidine-2-carbonyl]amino]butanediamide;(2r)-2-amino-3-sulfanylpropanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.80 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
1-aminoindan-1,5-dicarboxylic acid
1-aminoindan-1,5-dicarboxylic acid: structure given in first source		2.0410
mecamylamine
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.		2.0410primary aliphatic amine
cycloheximide
Cycloheximide: Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.. cycloheximide : A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus.		1.9910antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
pyrrolidonecarboxylic acid
Pyrrolidonecarboxylic Acid: A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.. 5-oxo-L-proline : An optically active form of 5-oxoproline having L-configuration.		3.09505-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
argipressin (4-9)
argipressin (4-9): principal metabolite of argipressin; RN given refers to (all-L)-isomer		1.9810
arginine vasopressin
Arginine Vasopressin: The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.. argipressin : The predominant form of mammalian vasopressin (antidiuretic hormone). It is a nonapeptide containing an arginine at residue 8 and two disulfide-linked cysteines at residues of 1 and 6.		3.0950vasopressincardiovascular drug;
hematologic agent;
mitogen
scopolamine hydrobromide
[no description available]		2.0410
pituitrin
Pituitrin: A substance or extract from the neurohypophysis (PITUITARY GLAND, POSTERIOR).		1.9810
ConditionIndicatedRelationship StrengthStudiesTrials